HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.

Abstract
Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported. Various case reports concerning dapsone-induced agranulocytosis are reviewed.
AuthorsRamesh M Bhat, K Radhakrishnan
JournalLeprosy review (Lepr Rev) Vol. 74 Issue 2 Pg. 167-70 (Jun 2003) ISSN: 0305-7518 [Print] England
PMID12862258 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dapsone
Topics
  • Agranulocytosis (chemically induced)
  • Dapsone (adverse effects)
  • Fatal Outcome
  • Humans
  • Leprosy, Borderline (drug therapy, physiopathology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: